Ludwigshafen, Germany

Reinhard Spengler

This inventor holds 7 USPTO granted patents. Top assignees: Basf Aktiengesellschaft, Knoll Aktiengesellschaft. Active years: 1989-1997.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Reinhard Spengler. Retrieved from https://idiyas.com/inventor/reinhard-spengler

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.2

ph-index = 5

Forward Citations = 244(Granted Patents)


Company Filing History:


Years Active: 1989-1997

Loading Chart...
7 patents (USPTO):Explore Patents

Title: Reinhard Spengler: Innovator in Pharmaceutical Technologies

Introduction

Reinhard Spengler is a notable inventor based in Ludwigshafen, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative drug delivery systems. With a total of 7 patents to his name, Spengler's work has had a profound impact on the industry.

Latest Patents

Among his latest patents is a novel delayed-release form for pharmaceutical active compounds. This invention is characterized by a core containing the active compound and a diffusion-inhibiting, adhesive coating layer. The coating has a thickness ranging from 0.01 to 10 µm and consists of a chemical network applied through a plasma-assisted chemical deposition process. Another significant patent is for a solid depot drug form produced by melt extrusion at temperatures between 50°C and 200°C. This solid depot form is created by continuously shaping a mixture of 0.1 to 70% by weight of a pharmaceutical active ingredient with a polymer melt.

Career Highlights

Reinhard Spengler has worked with prominent companies in the pharmaceutical sector, including BASF Aktiengesellschaft and Knoll Aktiengesellschaft. His experience in these organizations has allowed him to refine his expertise in drug formulation and delivery systems.

Collaborations

Throughout his career, Spengler has collaborated with notable colleagues such as Dieter Horn and Axel Sanner. These partnerships have contributed to the advancement of his innovative projects and patents.

Conclusion

Reinhard Spengler's contributions to pharmaceutical innovations demonstrate his commitment to improving drug delivery systems. His patents reflect a deep understanding of the complexities involved in pharmaceutical formulations. Spengler's work continues to influence the industry and pave the way for future advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…